Regulatory Updates

Latest News

Fasenra Approved for Children with Severe Asthma
Fasenra Approved for Children with Severe Asthma

April 11th 2024

Fasenra is now approved to treat patients aged 6 and older with eosinophilic asthma, a rare form of asthma.

 jolygon-stock.adobe.com
Drugs to Watch: Mental Health Conditions

April 11th 2024

appledesign-stock.adobe.com
Drugs to Watch: Lung Cancer

April 10th 2024

FDA Issues Second CRL for Parkinson’s Therapy
FDA Issues Second CRL for Parkinson’s Therapy

April 8th 2024

FDA Accepts Supplemental BLA for Bimzelx in Hidradenitis Suppurativa
FDA Accepts Supplemental BLA for Bimzelx in Hidradenitis Suppurativa

April 4th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.